PRENATAL DIAGNOSIS

Prenatal Phenotypic Analysis of Branchio-Oto-Renal Spectrum Disorder Attributable to EYA1 Gene Pathogenic Variants and Systematic Literature Review
Tian Y, Lv Y, Wang H, Che J, Cui F, Guo J, Tian W, Peng J, Yang B, Li H, Zhou B, Zhu X, Cui X and Liu L
Branchio-oto-renal (BOR) spectrum disorders are linked to pathogenic variants in the EYA1 gene, presenting significant challenges for prenatal ultrasound screening due to their phenotypic variability and complexity. Understanding these disorders' phenotypic expressions and genetic foundations is crucial.
Hypospadias Associated With Fetal Growth Restriction: A Multicentric Descriptive and Prognostic Cohort Study
Marquet M, Anselem O, Bouvattier C, Vivanti AJ, Benachi A, Jouannic JM, Picone O, Rosenblatt J, Salomon LJ, Tsatsaris V and Athiel Y
To determine the prevalence of genetic and endocrine abnormalities and to assess fetal, neonatal and surgical outcomes in cases of hypospadias associated with fetal growth restriction.
Heterozygous Beta-Thalassaemia in Pregnancy: Two Rare Causes of Severe Fetal Anemia Requiring Intrauterine Blood Transfusions
van der Meij E, Smiers FJW, Koopmann TT, Krapels I, LePoole K, Lopriore E, Middeldorp JM, Ootjers CS, Scharnhorst V, Scheepers HCJ, Harteveld CL and Verweij EJTJ
In this article, we present two cases of severe fetal hemolytic anemia based on a beta-thalassaemia trait inherited from a single parent.
Post-Abortem Detection of a Pathogenic Somatic PIK3CA-Variant in an Abdominal Lymphangioma That Is Not Present in Cultured Amniotic Fluid Cells
Roggia C, Ballin N, Faust U, Kagan KO and Dufke A
'I Could Trust It': Experiences of Reciprocal Translocation Carriers and Their Partners With Prenatal Cell-Free DNA Screening for Unbalanced Translocations
Cifuentes Ochoa M, Archibald AD, Flowers NJ and Pertile MD
To explore the experiences of people having cfDNA screening to detect unbalanced translocations, and to understand motivations for choosing this option.
Exome Sequencing in Fetuses With Bilateral Renal Agenesis Identified on Second Trimester Ultrasound: A Single Referral Center Experience
Yu QX, Zhen L, Xiao ZQ, Wen YJ and Li DZ
To determine the exome sequencing results in fetuses with bilateral renal agenesis (BRA).
Use of Prenatal Exome Sequencing: Opinion Statement of the French Federation of Human Genetics Working Group
Cogan G, Troadec MB, Devillard F, Saint-Frison MH, Geneviève D, Vialard F, Rial-Sebbag E, Héron D, Attie-Bitach T, Benachi A and Saugier-Veber P
Prenatal whole exome sequencing (pES) is increasingly prescribed for fetuses with ultrasound anomalies. Starting from the local French prenatal medicine practice, healthcare system and legal landscape, we aimed to address the broad medical and ethical issues raised by the use of pES for women and couples as well as for prenatal care providers.
Do We Really Want to Go Fishing for Foetal CC Dysgenesis (Whatever This Means…)? Extreme Caution is Needed
Paladini D
Response to Correspondence: "Do We Really Want to Go Fishing for Fetal CC Dysgenesis (Whatever This Means…)? Extreme Caution is Needed"
Rodríguez MA
Identification of a Mosaic Variant in the SYNCRIP Gene Causing Foetal Periventricular Nodular Heterotopia, Abnormal Sulcation and Infratentorial Anomaly
Birnbaum R, Malinger G, Ben Sira L, Goldenberg-Furmanov M, Miremberg H, Shohat M and Haratz KK
Fetal Presentation of MYRF-Related Cardiac Urogenital Syndrome: An Emerging and Challenging Prenatal Diagnosis
Favier M, Brischoux-Boucher E, Pyle LC, Mottet N, Auber-Lenoir M, Cattin J, Dahlen E, Cabrol C, Arbez-Gindre F, Attié-Bitach T, Boute O, Devisme L, Trost D, Boughalem A, Chitayat D, Prasov L, Chorin O, Rein-Rothschild A, Kassif E, Weissbach T, Hendon LG, Adam MP, Quelin C, Jaillard S, Mary L, Aukema SM, Heijligers M, de Die-Smulders C, Stegmann S, Badalato L, Ben-Yehuda A, Beneteau C, Forey PL, Kuentz P and Piard J
MYRF-related cardiac-urogenital syndrome (MYRF-CUGS) is a rare condition associated with heterozygous MYRF variants. The description of MYRF-CUGS phenotype is mostly based on postnatal cases and 36 affected individuals have been published so far. We aim now to delineate the prenatal phenotype of MYRF-CUGS by reporting clinical data from fetuses and neonates with a pathogenic MYRF variant.
Prenatal Diagnosis of Warsaw Breakage Syndrome: Fetal Compound Heterozygous Variants in the DDX11 Gene Associated With Growth Restriction, Cerebral, and Extra-Cerebral Malformations
Kratochwila C, Pomar L, Lebon S, Gengler C, Pavlidou DC, Good JM, Kumps C and Sichitiu J
Warsaw Breakage Syndrome (WABS) is a rare autosomal recessive cohesinopathy characterized by growth retardation and congenital anomalies. This report aims to highlight the prenatal diagnosis of WABS through ultrasound findings and genetic testing. We report a case of prenatal diagnosis of WABS in a 24-week gestation fetus exhibiting microcephaly, delayed sulcation, short corpus callosum, cerebellar vermis hypoplasia and intrahepatic portal-systemic shunts. The couple had a history of a prior pregnancy termination due to severe intrauterine growth restriction and cerebral malformations. Whole exome sequencing revealed compound heterozygous pathogenic variants [NM_030653.4:c.1403dupT, p.(Ser469Valfs*32) and c.1672C>T, p.(Arg558*)] in the DDX11 gene, consistent with WABS. The same pathogenic variants were identified in the prior terminated fetus upon subsequent analysis. Postmortem examination of the proband confirmed the prenatal ultrasound findings. This case expands the understanding of the prenatal phenotypic spectrum of WABS by identifying specific cerebral and extracerebral anomalies associated with pathogenic variants in the DDX11 gene. Incorporating advanced genetic diagnostics like whole exome sequencing into prenatal care provides valuable information for genetic counseling and management of rare genetic disorders.
Predictive Indicators and Outcomes of Pregnancies Affected by Stage I Twin-Twin Transfusion Syndrome Treated With Fetoscopic Laser Photocoagulation
Wagata M, Wada S, Sago H, Shimabukuro M, Nakata M, Iwagaki S, Takahashi Y, Konno H, Murakoshi T and Ishii K
The significance of fetoscopic laser photocoagulation (FLP) in stage I twin-twin transfusion syndrome (TTTS) remains controversial. This study aimed to clarify the outcomes and prognostic factors of stage I TTTS after FLP.
Abstracts of the ISPD 28th International Conference on Prenatal Diagnosis and Therapy, 7-10 July 2024, Boston
Contemporary Outcomes of a National Fetal Spina Bifida Surgery Service
Kik CC, Kunpalin Y, Kulkarni AV, Varghese A, Abbasi N, Ryan G, Dekoninck PLJ, Church PT, Malhotra A, Raghuram K, Kelly E and Van Mieghem T
To assess contemporary outcomes of fetuses who underwent open fetal spina bifida surgery in Canada.
Application of Genetic Origin Analysis of Copy Number Variations in Non-Invasive Prenatal Testing
Wang J, Zhu QW, Cui AM, Lin MS and Lou HQ
This study aimed to assess the application of origin analysis of copy number variations (CNVs) in non-invasive prenatal testing (NIPT) and provide a basis for expanding the clinical application of NIPT.
Aberrant Fetal Brain Sulcus Formation: A Clue to the Diagnosis of Sotos Syndrome
Luo C, Liu Y, Wang H, Chen L, Wu X, Geng Q, Wen H, Li S, Wu W and Zhong M
This study aims to elucidate two distinct fetal ultrasound features associated with aberrant brain sulcus formation as potential prenatal markers for Sotos syndrome caused by mutations in the NSD1 gene.
Short- and Long-Term Outcomes of Prenatally Identified Congenital Aqueductal Stenosis by Fetal MRI
Smith NJ, Nagaraj UD, Kline-Fath BM, Bierbrauer KS, Habli M and Venkatesan C
Providing accurate prenatal prognostication for expectant parents is challenging due to limited literature on factors impacting outcomes in children with congenital aqueductal stenosis (CAS). This study stratified CAS patients into isolated or complex categories (presence of additional intra- or extra-cranial anomalies or genetic syndromes) and evaluated both short- and long-term outcomes. Additionally, the role of ventricular rupture was assessed.
The Association of Prenatal Alcohol Exposure With Brain Development During the First 1000 Days of Life: A Systematic Review
Pielage M, Rousian M, van Heteren S, Groenenberg IAL, Hillegers MHJ, Steegers EAP and Marroun HE
Prenatal exposure to alcohol (PAE) can impact short- and long-term offspring health. However, knowledge on PAE and brain development in early life is limited. This systematic review investigated associations between PAE and brain development during the first 1000 days of life, and was registered in PROSPERO at CRD42022355144. The literature search was performed from inception until February 2024 in EMBASE, MEDLINE, Web of Science, PsycINFO, and the Cochrane Library. Studies investigating PAE and brain development during the first 1000 days using ultrasound, magnetic resonance imaging (MRI) or diffusion tensor imaging (DTI) were included. Our search initially identified 3618 articles, of which 16 were included. The findings suggest inconsistent associations between PAE and early brain development. Ultrasound studies on PAE and brain size report no clear relationship. Some postnatal MRI studies reported smaller thalami, amygdalae and hippocampi in alcohol exposed neonates. Postnatal DTI studies (n = 5) examining network integrity and connectivity reported bidirectional results in multiple brain networks. Our results highlight the need for further research on first trimester brain development, timing and quantity of alcohol exposure using a core set of validated instruments. Longitudinal assessments and standardized procedures for neuroimaging are crucial to understand the impact of PAE on early brain development.
The Challenges of Performing Exome Sequencing in Structurally Normal Fetuses
Chandler N, Holder-Espinasse M and Mone F
Screening and Predictive Biomarkers for Down Syndrome Through Amniotic Fluid Metabolomics
Zhang LC, Yang XC, Jiang YH, Yang Z, Yan LL, Zhang YX, Li Q, Tian LY, Cao J, Zhou Y, Wu SS, Zhuang DY, Chen CS and Li HB
Down syndrome (DS) is a congenital disorder caused by the presence of an extra copy of all or part of chromosome 21. It is characterized by significant intellectual disability, distinct facial features, and growth and developmental challenges. The utilization of metabolomics to analyze specific metabolic markers in maternal amniotic fluid may provide innovative tools and screening methods for investigating the early pathophysiology of trisomy 21 at the functional level.